BREA, Calif., Jan. 4, 2018 /PRNewswire/ — Beckman Coulter Diagnostics today announced the addition of 6-Acetylmorphine (6-AM) and Buprenorphine (BUP) assays to its broad menu of drugs-of-abuse tests that meet the demands of onsite testing laboratories. Laboratories worldwide using…
